Pepgen to participate in the stifel 2023 cns days conference

Boston, march 21, 2023 (globe newswire) -- pepgen inc. (nasdaq: pepg), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that james mcarthur, ph.d., president and ceo of pepgen will present at stifel's cns days conference on tuesday, march 28th at 1:30pm est.
PEPG Ratings Summary
PEPG Quant Ranking